Drugs Made In America Acquisition II Corp Right
DMIIR
64 hedge funds and large institutions have $2.71M invested in Drugs Made In America Acquisition II Corp Right in 2026 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 9 reducing their positions, and 1 closing their positions.
541% more capital inflows, than outflows
Capital inflows: $273K | Capital outflows: $42.6K
400% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 1
3% more funds holding
Funds holding: 62 → 64 (+2)
44% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LMR Partners
London,
United Kingdom
|
+$156K |
| 2 |
Cantor Fitzgerald
New York
|
+$49.6K |
| 3 |
O'Connor Alternative Investments
New York
|
+$48.4K |
| 4 |
SummitTX Capital
Fort Worth,
Texas
|
+$7.79K |
| 5 |
GTS Securities
Miami,
Florida
|
+$5.06K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$17.3K |
| 2 |
Boothbay Fund Management
New York
|
-$8.48K |
| 3 |
Commonwealth of Pennsylvania Public School Employees Retirement System
Harrisburg,
Pennsylvania
|
-$4.16K |
| 4 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
-$3.8K |
| 5 |
Shaolin Capital Management
Miami,
Florida
|
-$3.61K |
DMIIR Hedge Fund Activity: Q3 2026 in Review
64 of the 8,227 institutional investors tracked by Wall St. Rank reported a position in Drugs Made In America Acquisition II Corp Right (DMIIR) for Q3 2026, worth a combined $2.71M — down 18% from $3.31M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new DMIIR positions and 1 closed out — a net gain of 4 holders — while 5 added to existing stakes and 9 trimmed.
The largest buyer was LMR Partners, opening a new position worth an estimated $156K. The largest seller was Hudson Bay Capital Management, cutting an estimated $17.3K.
- 64 institutional investors held Drugs Made In America Acquisition II Corp Right (DMIIR) as of Q3 2026, up from 62 in Q2 2026.
- Funds reported $2.71M of Drugs Made In America Acquisition II Corp Right stock for Q3 2026, down 18% quarter-over-quarter.
- 5 funds opened new Drugs Made In America Acquisition II Corp Right positions in Q3 2026 and 1 closed out, a net change of +4 holders.
- The largest Drugs Made In America Acquisition II Corp Right buyer in Q3 2026 was LMR Partners, an estimated $156K added.
- The largest Drugs Made In America Acquisition II Corp Right seller in Q3 2026 was Hudson Bay Capital Management, an estimated $17.3K sold.
Based on aggregated 13F filings for Q3 2026.